TGR is a specialist immunoassay technology company. Underpinning TGR’s immunoassays is CaptSure™ – a patented antibody immobilisation system that delivers improvements in assay speed, simplicity and performance. Applications include bead-based assays, ELISA, lateral flow, and microfluidics for both life sciences and diagnostics markets.

TGR’s flagship product range, SureFire® Ultra™, caters for high throughput analysis of phosphoproteins using a no-wash, bead-based technology. The ELISA-ONE™ and CaptSure™ DIY ELISA assay systems also provide faster, easier ELISA assays to the more traditional immunoassay marketplace.

TGR has recently expanded its CaptSure™ technology to multiplexing, including its application to SureFire® Ultra™ Multiplex, with benefits applicable to other immunoassay systems.

TGR’s CaptSure™ technology is available for licensing and collaboration with external parties.